Gut Talk

著者： Sameer K. Berry MD and William D. Chey MD
無料で聴く

  • サマリー

  • Sameer K. Berry, MD, and William D. Chey, MD, host this Healio podcast that provides busy clinicians with quick updates that directly affect their GI practices. Through interviews and candid conversations, they explore how health policy, social media, technology, nutrition, practice management and research impact the field of Gastroenterology. Most importantly, the show also features interviews with patients to add a unique perspective on the topics that matter.
    続きを読む 一部表示

あらすじ・解説

Sameer K. Berry, MD, and William D. Chey, MD, host this Healio podcast that provides busy clinicians with quick updates that directly affect their GI practices. Through interviews and candid conversations, they explore how health policy, social media, technology, nutrition, practice management and research impact the field of Gastroenterology. Most importantly, the show also features interviews with patients to add a unique perspective on the topics that matter.
身体的病い・疾患 衛生・健康的な生活 生物科学
続きを読む 一部表示
エピソード
  • Predicting the future of GI with Brad Stillman

    Predicting the future of GI with Brad Stillman
    2024/10/23

    In this podcast episode, Brad Stillman, executive director at American College of Gastroenterology, discusses adapting with the GI landscape to prevent physician burnout, the role organizations play in ensuring physicians have the right tools to aid patients and more.

    • Intro :24
    • The interview/about Stillman :35
    • Can you tell us about your background? 1:17
    • Who are your early influences? Who was foundational for the way you think and the person you are? 1:54
    • Since your father was an artist, did you ever think about a career in art? 5:11
    • How did you choose law as your vocation? 7:23
    • From law, how did you get to the American College of Gastroenterology (ACG)? 8:47
    • Over the twenty-three years that you have been involved with ACG, what has struck you about how gastroenterology has changed as a subspecialty and as a profession? 14:26
    • Chey and Stillman on the structural challenges facing GI practices and screenings. 18:01
    • What needs to happen to address the crisis of training additional gastroenterologists to meet rising demands? 23:39
    • Chey, Berry and Stillman on creative solutions and being disruptive innovators in medical education reform. 29:09
    • How has the ACG changed over the course of your tenure? What have the most profound changes been in this organization? 33:07
    • Outside of education, how has it been managing the distinct components of the ACG, and what do you see in the future for the structure of the ACG? 37:57
    • Do you have any “Stillman quotes” you’d like to share with us? 44:17
    • Can you share anything about the upcoming strategic plan that is slated to be released at the ACG's 2024 Annual Scientific Meeting & Postgraduate Course? 46:33
    • Thank you, Brad 49:10
    • Thanks for listening 49:29

    Brad Stillman is the executive director at American College of Gastroenterology, the leading professional organization for GI clinicians with more than 20,000 members. He oversees all aspects of the College as well as the ACG Institute for Clinical Research and Education where he also serves on the board.

    We’d love to hear from you! Send your comments/questions to guttalkpodcast@healio.com. Follow us on X @HealioGastro @sameerkberry @umfoodoc. For more from Stillman, follow @AmCollegeGastro on X.

    Disclosures: Berry, Chey and Stillman report no relevant financial disclosures.
    続きを読む 一部表示
    50 分
  • “Food: The Main Course with Dr. William Chey & Amanda Lynett, MS, RDN” – Crossover with Tuesday Night IBS Podcast

    “Food: The Main Course with Dr. William Chey & Amanda Lynett, MS, RDN” – Crossover with Tuesday Night IBS Podcast
    2024/09/10
    In this special crossover podcast episode, Tuesday Night IBS host Jeffrey Roberts, MSEd, BSc, and Kate Scarlata, MPH, RDN, are joined live by William Chey, MD, and Amanda Lynett, MS, RDN, at FOOD the Main Course Conference in Ann Arbor, MI. · Intro :02 · The interview/about Scarlata :27 · About Chey 1:07 · About Lynett 1:53 · Chey, over the course of your career, what prompted this area of interest for you? 2:47 · When did you first hear about FODMAPs in relationship to IBS, and was there an “a-ha” moment that made you think that this would become something major in the future? 5:38 · What was your goal with this conference, FOOD the Main Course? 10:28 · Amanda, how do you go about putting a conference like this together? 14:09 · Where do you see GI nutrition going? What are some new updates in this area for dieticians? 18:45 · Amanda, what personally prompted you to go into GI nutrition? 22:03 · Chey, where do you think IBS care is going, and are we succeeding in helping patients? 24:37 · Do you feel that there is a role for supplements, prebiotics and probiotics in managing IBS? 28:26 · What about mast cell stabilizers? 30:49 · Do you have any recommendations right now for health care providers caring for patients with IBS? 33:56 · Do you think there is an opportunity to educate providers about pelvic floor physical therapy from a diet and awareness perspective? 39:21 · Amanda, as an expert GI RD, where do you see IBS care going, and what hopeful messages can you provide to people living with this condition? 42:41 · If you could speak to other health care professionals that work in GI, what is an important component that should be considered when offering nutrition care for patients living with a GI disorder? 44:17 · Thank you, Dr. Chey and Amanda 49:26 · Thanks for listening 49:42 Amanda Lynett MS, RDN, is a registered dietitian with her masters. Amanda is with the Division of Gastroenterology at Michigan Medical in Ann Arbor. Jeffrey Roberts, MSEd, BSc, is a patient advocate and creator of the first website for IBS sufferers. He is the co-founder of Tuesday Night IBS. Kate Scarlata, MPH, RDN, is a US-based dietitian with over 30 years of experience. Kate’s expertise is in gastrointestinal disorders and food intolerance. We’d love to hear from you! Send your comments/questions to guttalkpodcast@healio.com. Follow us on X @HealioGastro @sameerkberry @umfoodoc. For more Tuesday Night IBS, be sure check out TuesdayNightIBS.com and to follow and subscribe to their podcast. Disclosures: Chey and Roberts report no relevant financial disclosures. Scarlata reports stock options with Epicured LLC and FODY Food Company, financial support from Dr. Schar, Mahana Therapeutics, Nestle Health Science, Olipop, Pendulum, QOL Medical.
    続きを読む 一部表示
    50 分
  • Tom McCourt on discovery, trust, friendship and courage

    Tom McCourt on discovery, trust, friendship and courage
    2024/08/21

    In this podcast episode, Tom McCourt, chief executive officer of Ironwood Pharmaceuticals, discusses the evolving relationship between physicians and pharma, breakthroughs in GI drugs and more.

    • Intro :59
    • Welcome to this episode of Gut Talk 1:23
    • The interview/about McCourt 1:32
    • Tell us about your family and where you grew up. 2:15
    • What did you take away from your football career at University of Wisconsin? 4:19
    • How long were you a clinical pharmacist? 7:57
    • McCourt on his experience as a health science associate. 8:55
    • Where is the line between academics and the pharma industry? 10:49
    • When you launched drugs like omeprazole and esomeprazole, did you have any idea what impact they would have? 13:00
    • What changed to make the pharma industry go from respected to villainized? 16:39
    • What’s your perspective on innovation and billing architecture for pharmaceuticals? […] Where do you think we’re going to see the most exciting changes in the near-term? 19:33
    • Chey and McCourt on challenges the US health care system faces in comparison to other countries. 24:47
    • How can we make breakthrough drugs and technology available to everyone without stifling innovation? 27:05
    • Did patients valuing their quality-of-life factor into your decision to switch from AmGen to Ironwood Pharmaceuticals? 29:12
    • From a pharmaceutical perspective, do you think there are examples of successful health policy? 36:30
    • Thank you, Tom 42:13
    • Thanks for listening 43:20

    Tom McCourt is the chief executive officer of Ironwood Pharmaceuticals, a commercial biotechnology company working to revolutionize the treatment of gastrointestinal (GI) diseases and redefine the standard of care for millions of patients.

    We’d love to hear from you! Send your comments/questions to guttalkpodcast@healio.com. Follow us on X @HealioGastro @sameerkberry @umfoodoc. For more from McCourt, follow @ironwoodpharma on X.

    Disclosures: Berry and Chey report no relevant financial disclosures. McCourt is chief executive officer and a member of the board of directors of Ironwood Pharmaceuticals; serves on the board of directors and member of the compensation committee of Pliant Therapeutics, Inc., a public company, and on the board of trustees for the American Society of Gastrointestinal Endoscopy (ASGE).

    続きを読む 一部表示
    43 分

Gut Talkに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。